Nanoly Bioscience Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 7

Nanoly Bioscience General Information

Description

Developer of a biocompatible polymer technology designed to stabilize temperature-sensitive protein molecules during storage, transport, and use. The company's technology offers a revolutionary type of additive that can extend the temperature-controlled shelf life of unstable molecules and also completely eliminate the need for temperature-controlled storage for some, enabling clients to eliminate refrigeration for vaccines and protein therapeutics.

Contact Information

Website
www.nanoly.info
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 9066 East Colorado Circle
  • Denver, CO 80231
  • United States
+1 (720) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanoly Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jan-2017 00.000 Completed Generating Revenue
5. Seed Round 10-May-2016 00.000 00.000 000.00 Completed Generating Revenue
4. Grant 14-Feb-2016 0000 Completed Generating Revenue
3. Grant 13-Nov-2014 0000 Completed Generating Revenue
2. Grant 17-Sep-2014 $75K Completed Generating Revenue
1. Grant 01-Jan-2013 $65K Completed Generating Revenue
To view Nanoly Bioscience’s complete valuation and funding history, request access »

Nanoly Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 000,000 00.000000 00 00.00 00.00 00 00.00 000
To view Nanoly Bioscience’s complete cap table history, request access »

Nanoly Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biocompatible polymer technology designed to stabilize temperature-sensitive protein molecules during sto
Biotechnology
Denver, CO
7 As of 2020
00.000
000000000000 00.000

000000 0

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
000000000 00000 (0000000000)
Cambridge, MA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanoly Bioscience Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 000.00 00000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

Nanoly Bioscience Executive Team (7)

Name Title Board Seat Contact Info
Balaji Sridhar Ph.D Co-Founder, Chief Executive Officer & Board Member
Mark Tibbitt Ph.D Co-Founder & Chief Technology Officer
Nanxi Liu Co-Founder, Board Member & Chief Financial Officer
You’re viewing 3 of 7 executive team members. Get the full list »

Nanoly Bioscience Board Members (2)

Name Representing Role Since
Balaji Sridhar Ph.D Nanoly Bioscience Co-Founder, Chief Executive Officer & Board Member 000 0000
Nanxi Liu Self Co-Founder, Board Member & Chief Financial Officer 000 0000
To view Nanoly Bioscience’s complete board members history, request access »

Nanoly Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanoly Bioscience Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
iCatalysts Accelerator/Incubator Minority 000 0000 000000 0
OS Fund Venture Capital Minority 000 0000 000000 0
Colorado Office of Economic Development & International Trade SBIC 000 0000 000000 0
Katherine M. Swanson Young Innovator Award Other 000 0000 000000 0
Dell Technologies Corporation 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »